Home
- Naturade Significantly Strengthens Balance Sheet; Receives $2.5 Million in Capital from Westgate Equity Partners, L.P.
- Natrol Appoints Vincent Andrich VP Sales for Prolab Division
- Vermont Pure Holdings, Ltd. Announces Record Fiscal Year 2001 Results
- Body Shop Reports 24.8 Mil Euro Sales Revenues
- Spectrum Organic Products Responds to FDA Letter Regarding Use of Non-GMO Seal on Canola Oil Label
- Supplement Group Targets Consumer Education
- Advanced Nutraceuticals, Inc. Announces 2001 Year End Results And Additional Financing
- ADM Awarded Nutraceuticals Patent Patent Creates Proprietary Position for ADM in Fast-Growing Nutraceutical Market
- Tantivy Sciences Obtains Exclusive License to Unique Nutraceutical Products
- Top GNC Executives Tour Pittsburgh Market to Present New Business Plan and Expansion Possibilities; Meeting will focus on new business strategies and growth
- Nutrition 21 Receives Patent For the Nutritional Treatment of Type 2 Diabetes; Patent Presents New Pharmaceutical Licensing Opportunities
- ConsumerLab.com Finds Most B-vitamin Supplements Contain What They Claim, But Often Exceed Safe Levels - Consumers Cautioned to Be Aware of Side Effects with High Dose Products
- Nutraceutix, Inc., Nutravite Announcement Commercial Availability of CDT™ Glucosamine for Canadian Marketplace
- Harvey Kamil Appointed President of NBTY, Inc. - Scott Rudolph to Continue as Chairman and CEO
- drugstore.com Expects to Reach Profitability Target in 2003
- Human Genome Project Leads to Innovative Healthcare
- NPIcenter’s Career Center targets nutraceutical Industry
- Adding Vitamin C To Certain Drugs May Help Treat Alzheimer's, Other Brain Disorders
- Adding Vitamin C To Certain Drugs May Help Treat Alzheimer's, Other Brain Disorders
- Editorial: An Exercise in Synergy
- NBTY, Inc. Appoints Harvey Kamil President, Scott Rudolph To Continue As Chairman And CEO
- Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids
- Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids
- Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids
- LignisulMSM vs Naproxen for Osteoarthritis Clinical Trial Gets Underway
- Natural Health Trends Corp. Launches Lexxus Taiwan
- FDA Presents Compliance Guide for Structure/Function Claims
- New TrimFit® Bars Redefine Energy Bar Category
- New TrimFit® Bars Redefine Energy Bar Category
- Probiata® Offers Safe, Natural and Effective Alternative
- Alive & Well with Michelle Harris
- Be Well and Get Rewarded! Find Personalized Wellness Solutions and Earn Free Vitamins at NatureMade.com
- Consumers Search for Healthy Cleaning Products That Work
- Nordic Naturals: Omega 3 Fatty Acids
- Cyanotech Names Bob Capelli as Director of Sales
- Zuellig Group Nutrition and Ingredients (ZGNI) Appoints Bill Murphy General Manager
Company announces appointment of Bill Murphy to general manager of the Zuellig Functional Food Ingredients (ZFFI) business unit, to lead ZGNI's entry into the premix and food ingredients market.
- Zuellig Group Nutrition and Ingredients (ZGNI) Appoints Bill Murphy General Manager
Company announces appointment of Bill Murphy to general manager of the Zuellig Functional Food Ingredients (ZFFI) business unit, to lead ZGNI's entry into the premix and food ingredients market.
- Zuellig Group Nutrition and Ingredients (ZGNI) Appoints Bill Murphy General Manager
Company announces appointment of Bill Murphy to general manager of the Zuellig Functional Food Ingredients (ZFFI) business unit, to lead ZGNI's entry into the premix and food ingredients market.
- Zuellig Group Nutrition and Ingredients (ZGNI) Appoints Bill Murphy General Manager
Company announces appointment of Bill Murphy to general manager of the Zuellig Functional Food Ingredients (ZFFI) business unit, to lead ZGNI's entry into the premix and food ingredients market.
- Zuellig Group Nutrition and Ingredients (ZGNI) Appoints Bill Murphy General Manager
Company announces appointment of Bill Murphy to general manager of the Zuellig Functional Food Ingredients (ZFFI) business unit, to lead ZGNI's entry into the premix and food ingredients market.
- NIH Study Examines the Efficacy and Safety of Glucosamine and Chondroitin in Promoting Knee Joint Health
Initial findings from GAIT study indicate that "combination glucosamine and chondroitin is effective in treating moderate to severe knee pain due to osteoarthritis".
- NIH Study Examines the Efficacy and Safety of Glucosamine and Chondroitin in Promoting Knee Joint Health
Initial findings from GAIT study indicate that "combination glucosamine and chondroitin is effective in treating moderate to severe knee pain due to osteoarthritis".
- NIH Study Examines the Efficacy and Safety of Glucosamine and Chondroitin in Promoting Knee Joint Health
Initial findings from GAIT study indicate that "combination glucosamine and chondroitin is effective in treating moderate to severe knee pain due to osteoarthritis".
- NIH Study Examines the Efficacy and Safety of Glucosamine and Chondroitin in Promoting Knee Joint Health
Initial findings from GAIT study indicate that "combination glucosamine and chondroitin is effective in treating moderate to severe knee pain due to osteoarthritis".
- NIH Study Examines the Efficacy and Safety of Glucosamine and Chondroitin in Promoting Knee Joint Health
Initial findings from GAIT study indicate that "combination glucosamine and chondroitin is effective in treating moderate to severe knee pain due to osteoarthritis".
- NIH Study Examines the Efficacy and Safety of Glucosamine and Chondroitin in Promoting Knee Joint Health
Initial findings from GAIT study indicate that "combination glucosamine and chondroitin is effective in treating moderate to severe knee pain due to osteoarthritis".
- Clinical Study Finds Ginkgo Extract EGb 761(R) Improves Quality of Life of Typical Alzheimer's Patients
Results of the double-blind, placebo-controlled trial were presented at the 21st International Conference of Alzheimer's Disease International, indicate that Ginkgo biloba extract EGb 761(R) (manufactured by the Dr. Willmar Schwabe Company), improve cognitive functions, neuropsychiatric symptoms and the ability to perform daily living activities among typical Alzheimer's patients.
- Clinical Study Finds Ginkgo Extract EGb 761(R) Improves Quality of Life of Typical Alzheimer's Patients
Results of the double-blind, placebo-controlled trial were presented at the 21st International Conference of Alzheimer's Disease International, indicate that Ginkgo biloba extract EGb 761(R) (manufactured by the Dr. Willmar Schwabe Company), improve cognitive functions, neuropsychiatric symptoms and the ability to perform daily living activities among typical Alzheimer's patients.
- Clinical Study Finds Ginkgo Extract EGb 761(R) Improves Quality of Life of Typical Alzheimer's Patients
Results of the double-blind, placebo-controlled trial were presented at the 21st International Conference of Alzheimer's Disease International, indicate that Ginkgo biloba extract EGb 761(R) (manufactured by the Dr. Willmar Schwabe Company), improve cognitive functions, neuropsychiatric symptoms and the ability to perform daily living activities among typical Alzheimer's patients.
- Clinical Study Finds Ginkgo Extract EGb 761(R) Improves Quality of Life of Typical Alzheimer's Patients
Results of the double-blind, placebo-controlled trial were presented at the 21st International Conference of Alzheimer's Disease International, indicate that Ginkgo biloba extract EGb 761(R) (manufactured by the Dr. Willmar Schwabe Company), improve cognitive functions, neuropsychiatric symptoms and the ability to perform daily living activities among typical Alzheimer's patients.
- Clinical Study Finds Ginkgo Extract EGb 761(R) Improves Quality of Life of Typical Alzheimer's Patients
Results of the double-blind, placebo-controlled trial were presented at the 21st International Conference of Alzheimer's Disease International, indicate that Ginkgo biloba extract EGb 761(R) (manufactured by the Dr. Willmar Schwabe Company), improve cognitive functions, neuropsychiatric symptoms and the ability to perform daily living activities among typical Alzheimer's patients.
- Industry Coalition Advises Against Use of Dietary Supplements as Remedy for Avian Flu
The trade associations of the dietary supplement industry urge industry to refuse to stock or sell any products that are presented as preventing, treating or curing avian flu, refrain from promoting any dietary supplement as a preventative, cure or treatment for avian flu, and arge those who believe they may have avian flu or may have come in contact with it should immediately contact a healthcare professional.
- Industry Coalition Advises Against Use of Dietary Supplements as Remedy for Avian Flu
The trade associations of the dietary supplement industry urge industry to refuse to stock or sell any products that are presented as preventing, treating or curing avian flu, refrain from promoting any dietary supplement as a preventative, cure or treatment for avian flu, and arge those who believe they may have avian flu or may have come in contact with it should immediately contact a healthcare professional.
- Industry Coalition Advises Against Use of Dietary Supplements as Remedy for Avian Flu
The trade associations of the dietary supplement industry urge industry to refuse to stock or sell any products that are presented as preventing, treating or curing avian flu, refrain from promoting any dietary supplement as a preventative, cure or treatment for avian flu, and arge those who believe they may have avian flu or may have come in contact with it should immediately contact a healthcare professional.
- Jarrow Formulas® Donates 20,000 Bottles of Product to The Vitamin Angel Alliance for Hurricane and Earthquake Victims
Jarrow Formulas®, Inc. has donated 20,000 bottles of vitamins – 10,000 each of its Women’s Multi and Kid’s Multi – to the Vitamin Angel Alliance for victims of the recent hurricanes and earthquake.
- Jarrow Formulas® Donates 20,000 Bottles of Product to The Vitamin Angel Alliance for Hurricane and Earthquake Victims
Jarrow Formulas®, Inc. has donated 20,000 bottles of vitamins – 10,000 each of its Women’s Multi and Kid’s Multi – to the Vitamin Angel Alliance for victims of the recent hurricanes and earthquake.
- Jarrow Formulas® Donates 20,000 Bottles of Product to The Vitamin Angel Alliance for Hurricane and Earthquake Victims
Jarrow Formulas®, Inc. has donated 20,000 bottles of vitamins – 10,000 each of its Women’s Multi and Kid’s Multi – to the Vitamin Angel Alliance for victims of the recent hurricanes and earthquake.
- New Scholarship to Honor the Late Dr. Khem Shahani
A newly established professorship at the University of Nebraska-Lincoln (UNL) honors the life of scientist and professor Khem M. Shahani while helping to continue his acclaimed research in healthy food bacteria.
- New Scholarship to Honor the Late Dr. Khem Shahani
A newly established professorship at the University of Nebraska-Lincoln (UNL) honors the life of scientist and professor Khem M. Shahani while helping to continue his acclaimed research in healthy food bacteria.
- New Scholarship to Honor the Late Dr. Khem Shahani
A newly established professorship at the University of Nebraska-Lincoln (UNL) honors the life of scientist and professor Khem M. Shahani while helping to continue his acclaimed research in healthy food bacteria.
- Solbar Restructures for New Challenges
Company restructures into two divisions with Assaf Gadish assuming responsibilities for the Commodities Soy division and Gidi Landsberger to lead Solbar's Specialty Products Division.
- Solbar Restructures for New Challenges
Company restructures into two divisions with Assaf Gadish assuming responsibilities for the Commodities Soy division and Gidi Landsberger to lead Solbar's Specialty Products Division.
- Solbar Restructures for New Challenges
Company restructures into two divisions with Assaf Gadish assuming responsibilities for the Commodities Soy division and Gidi Landsberger to lead Solbar's Specialty Products Division.
- Solbar Restructures for New Challenges
Company restructures into two divisions with Assaf Gadish assuming responsibilities for the Commodities Soy division and Gidi Landsberger to lead Solbar's Specialty Products Division.
- Solbar Restructures for New Challenges
Company restructures into two divisions with Assaf Gadish assuming responsibilities for the Commodities Soy division and Gidi Landsberger to lead Solbar's Specialty Products Division.
- FSANZ Invites Comment About Draft Health Claims Standard
Proposed standard has two levels of claims - general claims aboub content or general health about a non-serious disease, and then hig-level health claims in relation to a serious disease or condition.
- FSANZ Invites Comment About Draft Health Claims Standard
Proposed standard has two levels of claims - general claims aboub content or general health about a non-serious disease, and then hig-level health claims in relation to a serious disease or condition.
- FSANZ Invites Comment About Draft Health Claims Standard
Proposed standard has two levels of claims - general claims aboub content or general health about a non-serious disease, and then hig-level health claims in relation to a serious disease or condition.
- FSANZ Invites Comment About Draft Health Claims Standard
Proposed standard has two levels of claims - general claims aboub content or general health about a non-serious disease, and then hig-level health claims in relation to a serious disease or condition.
- FSANZ Invites Comment About Draft Health Claims Standard
Proposed standard has two levels of claims - general claims aboub content or general health about a non-serious disease, and then hig-level health claims in relation to a serious disease or condition.
- Database for New Dietary Ingredient Notifications Launches
The American Herbal Products Association (AHPA) and NPIcenter have collaborated to create a database for accessing all of the notifications that FDA has received since 1994 for new dietary ingredients (NDIs). The AHPA NDI Database launched on Monday, December 5, 2005, with a one-day-only open access trial period, before the subscription period began.
- Database for New Dietary Ingredient Notifications Launches
The American Herbal Products Association (AHPA) and NPIcenter have collaborated to create a database for accessing all of the notifications that FDA has received since 1994 for new dietary ingredients (NDIs). The AHPA NDI Database launched on Monday, December 5, 2005, with a one-day-only open access trial period, before the subscription period began.
- Database for New Dietary Ingredient Notifications Launches
The American Herbal Products Association (AHPA) and NPIcenter have collaborated to create a database for accessing all of the notifications that FDA has received since 1994 for new dietary ingredients (NDIs). The AHPA NDI Database launched on Monday, December 5, 2005, with a one-day-only open access trial period, before the subscription period began.
- Database for New Dietary Ingredient Notifications Launches
The American Herbal Products Association (AHPA) and NPIcenter have collaborated to create a database for accessing all of the notifications that FDA has received since 1994 for new dietary ingredients (NDIs). The AHPA NDI Database launched on Monday, December 5, 2005, with a one-day-only open access trial period, before the subscription period began.
- Database for New Dietary Ingredient Notifications Launches
The American Herbal Products Association (AHPA) and NPIcenter have collaborated to create a database for accessing all of the notifications that FDA has received since 1994 for new dietary ingredients (NDIs). The AHPA NDI Database launched on Monday, December 5, 2005, with a one-day-only open access trial period, before the subscription period began.
- Database for New Dietary Ingredient Notifications Launches
The American Herbal Products Association (AHPA) and NPIcenter have collaborated to create a database for accessing all of the notifications that FDA has received since 1994 for new dietary ingredients (NDIs). The AHPA NDI Database launched on Monday, December 5, 2005, with a one-day-only open access trial period, before the subscription period began.
- Database for New Dietary Ingredient Notifications Launches
The American Herbal Products Association (AHPA) and NPIcenter have collaborated to create a database for accessing all of the notifications that FDA has received since 1994 for new dietary ingredients (NDIs). The AHPA NDI Database launched on Monday, December 5, 2005, with a one-day-only open access trial period, before the subscription period began.
- Study Finds Omega-3 Fatty Acids Help Decrease Postpartum Depression
randomized dose-ranging pilot trial of Omega-3 fatty acids for post-partum depression indicates that scores on depression measures decreased by approximately 50 percent, and were statistically significant.
- Study Finds Omega-3 Fatty Acids Help Decrease Postpartum Depression
randomized dose-ranging pilot trial of Omega-3 fatty acids for post-partum depression indicates that scores on depression measures decreased by approximately 50 percent, and were statistically significant.
- Study Finds Omega-3 Fatty Acids Help Decrease Postpartum Depression
randomized dose-ranging pilot trial of Omega-3 fatty acids for post-partum depression indicates that scores on depression measures decreased by approximately 50 percent, and were statistically significant.
- Study Finds Omega-3 Fatty Acids Help Decrease Postpartum Depression
randomized dose-ranging pilot trial of Omega-3 fatty acids for post-partum depression indicates that scores on depression measures decreased by approximately 50 percent, and were statistically significant.
- Study Finds Omega-3 Fatty Acids Help Decrease Postpartum Depression
randomized dose-ranging pilot trial of Omega-3 fatty acids for post-partum depression indicates that scores on depression measures decreased by approximately 50 percent, and were statistically significant.
- AEterna Zentaris subsidiary, Atrium Biotechnologies, acquires Douglas Laboratories in the U.S.
Atrium Biotechnologies Inc. has acquired HVL Inc., whose main brand is Douglas Laboratories for the total amount of $107 million ($US 92 million), approximately 6.4 times the adjusted EBITDA generated by Douglas.
- AEterna Zentaris subsidiary, Atrium Biotechnologies, acquires Douglas Laboratories in the U.S.
Atrium Biotechnologies Inc. has acquired HVL Inc., whose main brand is Douglas Laboratories for the total amount of $107 million ($US 92 million), approximately 6.4 times the adjusted EBITDA generated by Douglas.
- AEterna Zentaris subsidiary, Atrium Biotechnologies, acquires Douglas Laboratories in the U.S.
Atrium Biotechnologies Inc. has acquired HVL Inc., whose main brand is Douglas Laboratories for the total amount of $107 million ($US 92 million), approximately 6.4 times the adjusted EBITDA generated by Douglas.
- Health Wright Products Announces Major Expansion
Company announces the acquisition and development of a new 120,350 square foot facility in Clackamas, OR; new facility is expected to be completed and fully functional in early 2006.
- Health Wright Products Announces Major Expansion
Company announces the acquisition and development of a new 120,350 square foot facility in Clackamas, OR; new facility is expected to be completed and fully functional in early 2006.
- Health Wright Products Announces Major Expansion
Company announces the acquisition and development of a new 120,350 square foot facility in Clackamas, OR; new facility is expected to be completed and fully functional in early 2006.
- Hyperforin Plasma Level Inconsistency Found in 2002 St. John’s Wort Study
An article that was quietly presented in a medical journal last summer reported significant disparities in hyperforin plasma levels in many of the participants in a study on St. John’s wort (Hypericum perforatum) and major depression that had been published in the Journal of the American Medical Association (JAMA) over 3 years earlier.
- Hyperforin Plasma Level Inconsistency Found in 2002 St. John’s Wort Study
An article that was quietly presented in a medical journal last summer reported significant disparities in hyperforin plasma levels in many of the participants in a study on St. John’s wort (Hypericum perforatum) and major depression that had been published in the Journal of the American Medical Association (JAMA) over 3 years earlier.
- Hyperforin Plasma Level Inconsistency Found in 2002 St. John’s Wort Study
An article that was quietly presented in a medical journal last summer reported significant disparities in hyperforin plasma levels in many of the participants in a study on St. John’s wort (Hypericum perforatum) and major depression that had been published in the Journal of the American Medical Association (JAMA) over 3 years earlier.
- 3rd Natural Health Product Research Conference: From Concept to Consumer- March 3 – 5, 2006 - Toronto, Canada
Subtitled 'From Concept to Consumer' this annual conference is the premiere NHP scientific event in North America, showcasing the year’s best original research and providing a critically needed forum for dialogue amongst NHP research stakeholders. It will be held March 3 – 5, 2006 in Toronto, Ontario, Canada.
- 3rd Natural Health Product Research Conference: From Concept to Consumer- March 3 – 5, 2006 - Toronto, Canada
Subtitled 'From Concept to Consumer' this annual conference is the premiere NHP scientific event in North America, showcasing the year’s best original research and providing a critically needed forum for dialogue amongst NHP research stakeholders. It will be held March 3 – 5, 2006 in Toronto, Ontario, Canada.
- 3rd Natural Health Product Research Conference: From Concept to Consumer- March 3 – 5, 2006 - Toronto, Canada
Subtitled 'From Concept to Consumer' this annual conference is the premiere NHP scientific event in North America, showcasing the year’s best original research and providing a critically needed forum for dialogue amongst NHP research stakeholders. It will be held March 3 – 5, 2006 in Toronto, Ontario, Canada.
- 3rd Natural Health Product Research Conference: From Concept to Consumer- March 3 – 5, 2006 - Toronto, Canada
Subtitled 'From Concept to Consumer' this annual conference is the premiere NHP scientific event in North America, showcasing the year’s best original research and providing a critically needed forum for dialogue amongst NHP research stakeholders. It will be held March 3 – 5, 2006 in Toronto, Ontario, Canada.
- 3rd Natural Health Product Research Conference: From Concept to Consumer- March 3 – 5, 2006 - Toronto, Canada
Subtitled 'From Concept to Consumer' this annual conference is the premiere NHP scientific event in North America, showcasing the year’s best original research and providing a critically needed forum for dialogue amongst NHP research stakeholders. It will be held March 3 – 5, 2006 in Toronto, Ontario, Canada.
- Celanese Has Sold Its omega-3 DHA Business to Lonza
Company has sold the omega-3 DHA business of its performance products segment Nutrinova to Lonza Ltd., Switzerland. Financial details of the deal were not disclosed.
- Celanese Has Sold Its omega-3 DHA Business to Lonza
Company has sold the omega-3 DHA business of its performance products segment Nutrinova to Lonza Ltd., Switzerland. Financial details of the deal were not disclosed.
- Celanese Has Sold Its omega-3 DHA Business to Lonza
Company has sold the omega-3 DHA business of its performance products segment Nutrinova to Lonza Ltd., Switzerland. Financial details of the deal were not disclosed.
- Celanese Has Sold Its omega-3 DHA Business to Lonza
Company has sold the omega-3 DHA business of its performance products segment Nutrinova to Lonza Ltd., Switzerland. Financial details of the deal were not disclosed.
- ORAFTI’s Synergy 1® Receives Natural Products Award
Orafti Active Food Ingredients has announced that its proprietary enriched inulin ingredient Synergy 1® has been honored as Editors’ Choice in Nutritional Outlook Magazine’s 2005 Natural Products Awards.
- ORAFTI’s Synergy 1® Receives Natural Products Award
Orafti Active Food Ingredients has announced that its proprietary enriched inulin ingredient Synergy 1® has been honored as Editors’ Choice in Nutritional Outlook Magazine’s 2005 Natural Products Awards.
- ORAFTI’s Synergy 1® Receives Natural Products Award
Orafti Active Food Ingredients has announced that its proprietary enriched inulin ingredient Synergy 1® has been honored as Editors’ Choice in Nutritional Outlook Magazine’s 2005 Natural Products Awards.
- EuroPharma® Selected As Exclusive Research And Development Team for Chicken Soup for the Soul(TM) Supplements
EuroPharma’s president Terry Lemerond has developed an exclusive line of supplements for the Chicken Soup for the Soul® brand to be marketed through a network of independent sales affiliates and direct response radio and TV advertising.
- EuroPharma® Selected As Exclusive Research And Development Team for Chicken Soup for the Soul(TM) Supplements
EuroPharma’s president Terry Lemerond has developed an exclusive line of supplements for the Chicken Soup for the Soul® brand to be marketed through a network of independent sales affiliates and direct response radio and TV advertising.
- Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award
The 2009 Frost & Sullivan European Functional Food & Beverage Microencapsulation Technology Innovation Award has been presented to GAT Food Essentials GmbH in recognition of its proprietary wowCAPS(R) technology.
- Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award
The 2009 Frost & Sullivan European Functional Food & Beverage Microencapsulation Technology Innovation Award has been presented to GAT Food Essentials GmbH in recognition of its proprietary wowCAPS(R) technology.
- Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award
The 2009 Frost & Sullivan European Functional Food & Beverage Microencapsulation Technology Innovation Award has been presented to GAT Food Essentials GmbH in recognition of its proprietary wowCAPS(R) technology.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- Synergy Flavors Invests in Sensory Flavor Profiling Research
Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients.
- Synergy Flavors Invests in Sensory Flavor Profiling Research
Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients.
- Synergy Flavors Invests in Sensory Flavor Profiling Research
Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients.
- Synergy Flavors Invests in Sensory Flavor Profiling Research
Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients.
- Synergy Flavors Invests in Sensory Flavor Profiling Research
Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- NPI Daily - Top of The News for Nov. 20, 2009 - FDA Issues 22 Warning Letters to Website Operators
Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award; Synergy Flavors Invests in Sensory Flavor Profiling Research; FDA Issues 22 Warning Letters to Website Operators; Nordic Naturals Ultimate Omega™ First Fish Oil to Participate in NFL/NFLPA Sports Nutrition Label Certification Program; BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates; New Organic Berry Whole Food Energy Bar from Amazing Grass Delivers Whole Food Nutrition; Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
- NPI Daily - Top of The News for Nov. 20, 2009 - FDA Issues 22 Warning Letters to Website Operators
Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award; Synergy Flavors Invests in Sensory Flavor Profiling Research; FDA Issues 22 Warning Letters to Website Operators; Nordic Naturals Ultimate Omega™ First Fish Oil to Participate in NFL/NFLPA Sports Nutrition Label Certification Program; BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates; New Organic Berry Whole Food Energy Bar from Amazing Grass Delivers Whole Food Nutrition; Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
- Heart Health Alert: Niacin May Reverse Hardening of the Arteries
- Heart Health Alert: Niacin May Reverse Hardening of the Arteries
- Heart Health Alert: Niacin May Reverse Hardening of the Arteries
- Heart Health Alert: Niacin May Reverse Hardening of the Arteries
- Spotlight on Savory Side Dishes
- Spotlight on Savory Side Dishes
- Spotlight on Savory Side Dishes
- Another Reason to Choose Healthy Lifestyle Habits
- Another Reason to Choose Healthy Lifestyle Habits
|
 Los Angeles, CA, November 30, 2005 – Los Angeles-based Jarrow Formulas’ announces the introduction of Pressure Optimizer™, a product that supports healthy blood pressure for those already within normal range.
PressureOptimizer’s™ primary constituent is AmealPeptide™, a patented extract of hydrolyzed casein that contains two tripeptides (Valyl-Prolyl-Proline, Isoleucyl-Prolyl-Proline) extensively clinically studied for their effect on blood pressure.
Coenzyme Q-10 is also included in the Pressure Optimizer™ formula. Jarrow Formulas, as a company, has supported clinical studies that have demonstrated the benefits of Co-Q10 in improving endothelial function and blood pressure. In addition, Co-Q10 supports heart function as a component of the electron transport system.
“Co-Q10 has antioxidant benefits as well,” says Dallas Clouatre, Ph.D, a consultant for Jarrow Formulas, “Co-Q10 protects mitochondrial membranes and cholesterol from free radical damage.”
Additional ingredients include magnesium and L-theanine. Magnesium helps to relax the blood vessels and serves as a natural calcium channel blocker. Theanine (gamma-ethylamino-L-glutamic acid) is a unique amino acid found in green tea. It is known to promote a state of alert relaxation. In two different studies using spontaneously hypertensive animal, administration of L-theanine led to significant reductions in blood pressure. Each of the components of the formula are each backed by science for blood pressure lowering benefits and the combination supports several distinct mechanisms for proper blood pressure regulation.
Jarrow Formulas is a nutritional supplement formulator and marketer founded in 1977 and incorporated in 1988. The company markets its products throughout the United States and internationally in more than 20 countries in Europe, Asia, Israel and Latin America. The company offers a complete line of nutritional products that includes vitamins, minerals, probiotics, standardized herbal concentrates, amino acids, enzymes and enteral nutrition formulations. Jarrow Formulas, Inc. is active in regulatory affairs, helping to maintain American’s rights to free access to dietary supplements. Its products are manufactured by Jarrow Industries Incorporated, a pharmaceutical quality facility located in Santa Fe Springs, CA. For more information, contact Mark Becker, Director, Advertising/Communications toll free at (800) 726-0886 or access the Jarrow Formulas Web site at www.Jarrow.com.
###
Contact:
Mark Becker
(800) 726-0886
becker@Jarrow.com |